tiprankstipranks
Advertisement
Advertisement

RIGL Stock Latest News

Rigel Appoints Alison Hannah as New Chief Medical Officer
Company AnnouncementsRigel Appoints Alison Hannah as New Chief Medical Officer
7d ago
8K
RIGL
Rigel appoints Alison Hannah as Chief Medical Officer and Vice President
PremiumThe Fly
Rigel appoints Alison Hannah as Chief Medical Officer and Vice President
7d ago
RIGL
Rigel Expands Oncology Portfolio with VEPPANU Global Rights
PremiumCompany Announcements
Rigel Expands Oncology Portfolio with VEPPANU Global Rights
21d ago
8K
RIGL
Rigel closes license agreement for Veppanu
PremiumThe Fly
Rigel closes license agreement for Veppanu
22d ago
PFE
ARVN
Pantginis Reiterates Buy on Rigel, Citing Strengthening Oncology Portfolio and Unchanged $57 Price Target
PremiumRatings
Pantginis Reiterates Buy on Rigel, Citing Strengthening Oncology Portfolio and Unchanged $57 Price Target
1M ago
RIGL
Rigel partner Kissei submits new drug application for olutasidenib in Japan
PremiumThe FlyRigel partner Kissei submits new drug application for olutasidenib in Japan
1M ago
RIGL
H.C. Wainwright highlights Rezlidhia NDA as expanding Rigel’s ex-U.S. reach
Premium
The Fly
H.C. Wainwright highlights Rezlidhia NDA as expanding Rigel’s ex-U.S. reach
1M ago
RIGL
Lilly and Rigel Advance RA Pipeline as Key LY3871801 Mid-Stage Trial Reaches Completion
Premium
Company Announcements
Lilly and Rigel Advance RA Pipeline as Key LY3871801 Mid-Stage Trial Reaches Completion
2M ago
LLY
RIGL
Rigel: Buy Rating Reiterated as New Oncology Data Support Franchise Strength and Unchanged $57 Price Target
PremiumRatings
Rigel: Buy Rating Reiterated as New Oncology Data Support Franchise Strength and Unchanged $57 Price Target
2M ago
RIGL
Rigel Shareholders Approve Equity Plans and Board Slate
PremiumCompany Announcements
Rigel Shareholders Approve Equity Plans and Board Slate
2M ago
8K
RIGL
Rigel Pharmaceuticals Highlights Growth Amid Rising Costs
PremiumCompany Announcements
Rigel Pharmaceuticals Highlights Growth Amid Rising Costs
2M ago
RIGL
Arvinas price target raised to $16 from $14 at BofA
PremiumThe Fly
Arvinas price target raised to $16 from $14 at BofA
2M ago
PFE
ARVN
Arvinas price target raised to $18 from $16 at BTIG
PremiumThe FlyArvinas price target raised to $18 from $16 at BTIG
2M ago
ARVN
RIGL
Rigel Pharmaceuticals price target raised to $81 from $69 at Citi
Premium
The Fly
Rigel Pharmaceuticals price target raised to $81 from $69 at Citi
2M ago
RIGL
Rigel Secures Global Rights to VEPPANU Breast Cancer Therapy
Premium
Company Announcements
Rigel Secures Global Rights to VEPPANU Breast Cancer Therapy
2M ago
8K
RIGL
H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’
PremiumThe Fly
H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’
2M ago
PFE
ARVN
Analyst Reiterates Buy on Rigel as VEPPANU Acquisition Expands Portfolio; Price Target Maintained at $57
PremiumRatings
Analyst Reiterates Buy on Rigel as VEPPANU Acquisition Expands Portfolio; Price Target Maintained at $57
2M ago
RIGL
Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu
PremiumThe Fly
Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu
2M ago
PFE
ARVN
Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer
PremiumThe Fly
Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer
2M ago
PFE
ARVN
Rigel Pharmaceuticals price target lowered to $69 from $71 at Citi
PremiumThe FlyRigel Pharmaceuticals price target lowered to $69 from $71 at Citi
2M ago
RIGL
Rigel Pharmaceuticals Signals Profitable Growth After Earnings Call
Premium
Company Announcements
Rigel Pharmaceuticals Signals Profitable Growth After Earnings Call
2M ago
RIGL
Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c
Premium
The Fly
Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c
2M ago
RIGL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >